Insider Selling: Cutera, Inc. (CUTR) EVP Sells 11,345 Shares of Stock

Cutera, Inc. (NASDAQ:CUTR) EVP Larry Laber sold 11,345 shares of the stock in a transaction on Friday, June 15th. The shares were sold at an average price of $43.43, for a total transaction of $492,713.35. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

Cutera traded down $1.35, reaching $43.05, during trading hours on Tuesday, MarketBeat reports. The stock had a trading volume of 198,100 shares, compared to its average volume of 223,682. The firm has a market cap of $591.74 million, a PE ratio of 57.01, a price-to-earnings-growth ratio of 3.81 and a beta of 0.48. Cutera, Inc. has a 52 week low of $23.85 and a 52 week high of $56.05.

Cutera (NASDAQ:CUTR) last announced its quarterly earnings results on Tuesday, May 8th. The medical device company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.01 by ($0.03). The firm had revenue of $34.10 million during the quarter, compared to the consensus estimate of $35.27 million. Cutera had a return on equity of 16.12% and a net margin of 18.54%. Cutera’s revenue was up 16.4% on a year-over-year basis. During the same period last year, the business earned ($0.07) EPS. sell-side analysts expect that Cutera, Inc. will post 0.57 earnings per share for the current year.

Several equities analysts recently commented on CUTR shares. Zacks Investment Research raised shares of Cutera from a “hold” rating to a “strong-buy” rating and set a $53.00 target price on the stock in a report on Wednesday, February 21st. BidaskClub lowered shares of Cutera from a “strong-buy” rating to a “buy” rating in a report on Tuesday, May 1st. Stifel Nicolaus started coverage on shares of Cutera in a report on Monday, April 16th. They set a “hold” rating and a $55.00 target price on the stock. ValuEngine lowered shares of Cutera from a “strong-buy” rating to a “buy” rating in a report on Wednesday, May 9th. Finally, Stephens started coverage on shares of Cutera in a report on Tuesday, March 13th. They set an “overweight” rating and a $60.00 target price on the stock. One investment analyst has rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and two have issued a strong buy rating to the stock. Cutera presently has a consensus rating of “Buy” and a consensus target price of $46.67.

A number of institutional investors have recently made changes to their positions in the business. BlackRock Inc. grew its holdings in Cutera by 33.2% in the 4th quarter. BlackRock Inc. now owns 2,015,640 shares of the medical device company’s stock worth $91,409,000 after acquiring an additional 502,933 shares during the last quarter. Renaissance Technologies LLC grew its holdings in Cutera by 3.6% in the 4th quarter. Renaissance Technologies LLC now owns 1,083,600 shares of the medical device company’s stock worth $49,141,000 after acquiring an additional 37,920 shares during the last quarter. Bank of New York Mellon Corp grew its holdings in Cutera by 49.4% in the 4th quarter. Bank of New York Mellon Corp now owns 218,421 shares of the medical device company’s stock worth $9,905,000 after acquiring an additional 72,223 shares during the last quarter. JPMorgan Chase & Co. grew its holdings in Cutera by 10.5% in the 1st quarter. JPMorgan Chase & Co. now owns 188,029 shares of the medical device company’s stock worth $9,449,000 after acquiring an additional 17,855 shares during the last quarter. Finally, Bogle Investment Management L P DE grew its holdings in Cutera by 77.2% in the 4th quarter. Bogle Investment Management L P DE now owns 185,174 shares of the medical device company’s stock worth $8,397,000 after acquiring an additional 80,700 shares during the last quarter. 93.36% of the stock is currently owned by institutional investors and hedge funds.

Cutera Company Profile

Cutera, Inc, a medical device company, designs, develops, manufactures, markets, and services laser and other energy based aesthetics systems worldwide. The company offers enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions; excel HR platform, a hair removal solution for various skin types; and truSculpt, a high-powered radio frequency platform designed for deep tissue heating.

Insider Buying and Selling by Quarter for Cutera (NASDAQ:CUTR)

Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply